Medical Condition News

RSS

FDA, American Society of Nephrology announce Kidney Health Initiative

The American Society of Nephrology (ASN) and the US Food and Drug Administration (FDA) are pleased to announce a new partnership: the Kidney Health Initiative (KHI).

28 Sep 2012

Cherry intake reduces risk of gout attacks

A new study found that patients with gout who consumed cherries over a two-day period showed a 35% lower risk of gout attacks compared to those who did not eat the fruit.

28 Sep 2012

ARIAD Pharmaceuticals completes rolling submission of ponatinib NDA with FDA

ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).

28 Sep 2012

Coalition for Pulmonary Fibrosis announces winners of 2012 annual awards for distinguished service

The Coalition for Pulmonary Fibrosis (CPF) proudly announces the winners of its three annual awards for distinguished service. Each honoree has made vital contributions to the effort to fight Pulmonary Fibrosis (PF) – in research, humanitarian and advocacy efforts.

28 Sep 2012

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Life Technologies Corporation today announced it has received FDA 510(k) clearance for its OpTmizer CTS T-Cell Expansion Tissue Culture Medium – a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials.

28 Sep 2012

Canadian Stroke Congress to take place from Sept. 30 to Oct. 2

Researchers from across Canada and around the world are gathering in Calgary for the largest-ever Canadian Stroke Congress, drawing much-needed attention to one of society's leading health issues. The Canadian Stroke Congress runs from Sept. 30 to Oct. 2 at the Calgary Telus Convention Centre.

28 Sep 2012

OncoGenex commences custirsen Phase 3 trial in non-small cell lung cancer

OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.

28 Sep 2012

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).

28 Sep 2012

AACAP announces new Practice Parameter on issues related to LGBT

The American Academy of Child and Adolescent Psychiatry (AACAP) is proud to announce its new Practice Parameter on issues related to and affecting gay, lesbian, bisexual, and gender variant youth.

27 Sep 2012

Hundreds of new genes are involved in function and development of T-cells

A research team led by investigators at New York University and NYU School of Medicine has determined how cells that cause inflammatory ailments, such as Crohn's disease, multiple sclerosis, and arthritis, differentiate from stem cells and ultimately affect the clinical outcome of these diseases.

27 Sep 2012

Leptin hormone may play a role in hearing and vision loss

Leptin - commonly dubbed the "fat hormone" - does more than tell the brain when to eat. A new study by researchers at The University of Akron and Northeast Ohio Medical University (NEOMED) shows that leptin may play a role in hearing and vision loss.

27 Sep 2012

George Mason University research makes big breakthrough in HIV

New research showing how the HIV virus targets "veterans" or memory T-cells could change how drugs are used to stop the virus, according to new research by George Mason University.

27 Sep 2012

Aeterna Zentari expects to file AEZS-130 NDA with FDA for adult growth hormone deficiency

Aeterna Zentaris Inc. today announced that it continues to expect to file a New Drug Application (NDA) early next year, for its oral ghrelin agonist, AEZS-130, as a diagnostic test for adult growth hormone deficiency (AGHD), after receiving notification from the United States Food and Drug Administration (FDA) that Fast Track designation had not been granted.

27 Sep 2012

Early, intensive therapy with adalimumab can help treat rheumatoid arthritis

Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication is applied right at the beginning of the illness.

27 Sep 2012

Cancer Institute of New Jersey to benefit from Panera Bread's Pink Ribbon Bagel

For more than a decade, "thinking pink" has been a tradition for Panera Bread bakery-cafés in their effort to highlight breast cancer awareness in their local communities during the month of October. That campaign, which marks National Breast Cancer Awareness Month, continues this year, with the offering of the Pink Ribbon Bagel.

27 Sep 2012

New spray could help avoid contact dermatitis

With more than half of all adults allergic to poison ivy, oak and sumac, scientists are reporting an advance toward an inexpensive spray that could reveal the presence of the rash-causing toxic oil on the skin, clothing, garden tools, and even the family cat or dog. Using the spray, described in ACS' The Journal of Organic Chemistry would enable people to wash off the oil, or avoid further contact, in time to sidestep days of misery.

27 Sep 2012